当前位置: X-MOL 学术Clin. Genet. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA-related overgrowth spectrum
Clinical Genetics ( IF 2.9 ) Pub Date : 2021-08-17 , DOI: 10.1111/cge.14047
Diana Carli 1, 2 , Silvia Kalantari 3 , Rosaria Manicone 2 , Paola Coppo 4 , Paola Francia di Celle 5 , Roberta La Selva 4 , Federica Santoro 6 , Carlotta Ranieri 7 , Simona Cardaropoli 1 , Franca Fagioli 2 , Giovanni Battista Ferrero 1, 8 , Nicoletta Resta 7 , Alessandro Mussa 1
Affiliation  

Kaposiform hemangioendothelioma (KHE) is a rare locally aggressive mixed vascular tumor, with typical onset in early childhood and characterized by progressive angio- and lymphangiogenesis. Its etiopathogenesis and molecular bases are still unclear. Here, we report the first case of congenital KHE harboring a PIK3CA mosaic pathogenic variant (c.323G > A, p.Arg108His) in a boy with very subtle PIK3CA-related overgrowth spectrum (PROS) features. This finding provides insights into the pathophysiology of KHE, offering targeted therapeutic options by inhibition of the PI3K/Akt/mTOR pathway. We propose the inclusion of this mixed lymphatic and vascular anomaly within the PROS.

中文翻译:

卡波西样血管内皮瘤进一步拓宽了 PIK3CA 相关过度生长谱的表型

卡波西样血管内皮瘤(KHE)是一种罕见的局部侵袭性混合血管肿瘤,典型发病于儿童早期,以进行性血管和淋巴管生成为特征。其发病机制和分子基础仍不清楚。在这里,我们报告了第一个具有PIK3CA嵌合致病性变异 (c.323G > A, p.Arg108His) 的先天性 KHE 病例,该男孩具有非常微妙的PIK3CA相关过度生长谱 (PROS) 特征。这一发现提供了对 KHE 病理生理学的见解,通过抑制 PI3K/Akt/mTOR 通路提供靶向治疗选择。我们建议将这种混合的淋巴和血管异常纳入 PROS。
更新日期:2021-10-07
down
wechat
bug